Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy
Przemysław M Jurek,* Konrad Zabłocki,* Urszula Waśko, Maciej P Mazurek, Jacek Otlewski, Filip Jeleń Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Poland *These authors contributed equally to this work Abstract: Compounds that recognize and strongly bind to mo...
Guardado en:
Autores principales: | Jurek PM, Zabłocki K, Waśko U, Mazurek MP, Otlewski J, Jeleń F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cdf25e99ec414be5bbe368454e6f58a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preparation and Evaluation of Doxorubicin-Loaded PLA–PEG–FA Copolymer Containing Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Cancer Treatment: Combination Therapy with Hyperthermia and Chemotherapy
por: Khaledian M, et al.
Publicado: (2020) -
Aptamer-Targeted Calcium Phosphosilicate Nanoparticles for Effective Imaging of Pancreatic and Prostate Cancer
por: Abraham T, et al.
Publicado: (2021) -
Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel
por: Yu Z, et al.
Publicado: (2020) -
Tumor-specific hyperthermia with aptamer-tagged superparamagnetic nanoparticles
por: Pala K, et al.
Publicado: (2013) -
Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins
por: Perepelyuk M, et al.
Publicado: (2016)